(Q71857088)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Treatment of combined hyperlipidemia with fluvastatin and gemfibrozil, alone or in combination, does not induce muscle damage (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

J W Smit

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

G H Jansen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

T W de Bruin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

D W Erkelens

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

language of work or name

English

0 references

publication date

1 July 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Cardiology

21 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

76

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

126A-128A

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980034-7

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980034-7

Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980034-7

Long-term treatment of hypercholesterolemia with fluvastatin: a 52-week multicenter safety and efficacy study. French-Dutch Fluvastatin Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2805%2980034-7

10.1016/S0002-9149(05)80034-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7604787%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference